|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
DE3689123T2
(de)
|
1985-11-01 |
1994-03-03 |
Xoma Corp |
Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5332583A
(en)
|
1987-11-24 |
1994-07-26 |
Connaught Laboratories Limited |
Vaccine containing genetically-detoxified pertussis holotoxin
|
|
US5244657A
(en)
|
1987-11-24 |
1993-09-14 |
Connaught Laboratories Limited |
Genetic detoxification of pertussis toxin
|
|
GB8727489D0
(en)
|
1987-11-24 |
1987-12-23 |
Connaught Lab |
Detoxification of pertussis toxin
|
|
US5221618A
(en)
|
1987-11-24 |
1993-06-22 |
Connaught Laboratories Limited |
Genetic detoxification of pertussis toxin
|
|
US5358868A
(en)
|
1987-11-24 |
1994-10-25 |
Connaught Laboratories Limited |
Genetic detoxification of pertussis toxin
|
|
NZ230747A
(en)
|
1988-09-30 |
1992-05-26 |
Bror Morein |
Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5736139A
(en)
*
|
1989-10-31 |
1998-04-07 |
Ochidian Pharmaceuticals, Inc. |
Treatment of Clostridium difficile induced disease
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5231003A
(en)
|
1990-05-11 |
1993-07-27 |
Cambridge Bioscience Corporation |
Monoclonal antibodies specific for toxin b of clostridium difficile
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
US5908635A
(en)
|
1994-08-05 |
1999-06-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for the liposomal delivery of nucleic acids
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
US6096716A
(en)
|
1994-12-12 |
2000-08-01 |
The Board Of Regents, The University Of Texas System |
Liposome-mediated transfection of central nervous system cells
|
|
AUPO517897A0
(en)
|
1997-02-19 |
1997-04-11 |
Csl Limited |
Chelating immunostimulating complexes
|
|
DE19739685A1
(de)
*
|
1997-09-10 |
1999-03-11 |
Eichel Streiber Christoph Von |
Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile
|
|
AUPP807399A0
(en)
|
1999-01-08 |
1999-02-04 |
Csl Limited |
Improved immunogenic lhrh composition and methods relating thereto
|
|
DE60044236D1
(de)
|
1999-02-17 |
2010-06-02 |
Csl Ltd |
Immunogene komplexe und methoden in bezug auf diese
|
|
US20040126829A1
(en)
|
2001-12-18 |
2004-07-01 |
Hildebrand William H. |
Anti-HLA assay and methods
|
|
GB0309126D0
(en)
|
2003-04-17 |
2003-05-28 |
Neutec Pharma Plc |
Clostridium difficile focussed antibodies
|
|
ES2366626T3
(es)
|
2004-02-06 |
2011-10-24 |
University Of Massachusetts |
Anticuerpos contra toxinas de clostridium difficile y usos de los mismos.
|
|
JP2008506789A
(ja)
|
2004-07-18 |
2008-03-06 |
シーエスエル、リミテッド |
インターフェロン−ガンマ応答強化を誘発するための免疫刺激複合体及びオリゴヌクレオチド処方物
|
|
EP1776105A2
(en)
|
2004-07-18 |
2007-04-25 |
Coley Pharmaceutical Group, Ltd |
Methods and compositions for inducing innate immune responses
|
|
WO2006044643A2
(en)
|
2004-10-15 |
2006-04-27 |
Seattle Genetics, Inc. |
Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
CA2592015A1
(en)
*
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
|
US7790203B2
(en)
|
2005-12-13 |
2010-09-07 |
Lowder Tom R |
Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
|
|
SG170091A1
(en)
|
2006-03-10 |
2011-04-29 |
Wyeth Corp |
Anti-5t4 antibodies and uses thereof
|
|
SG177168A1
(en)
*
|
2006-12-01 |
2012-01-30 |
Medarex Inc |
Human antibodies that bind cd22 and uses thereof
|
|
US7597891B2
(en)
|
2006-12-13 |
2009-10-06 |
Simon Michael R |
Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
|
|
WO2008114733A1
(ja)
*
|
2007-03-16 |
2008-09-25 |
Kyowa Hakko Kirin Co., Ltd. |
抗Claudin-4抗体
|
|
MX2010005282A
(es)
*
|
2007-11-13 |
2010-08-31 |
Teva Pharma |
Anticuerpos humanizados contra tl1a.
|
|
AU2009203464A1
(en)
|
2008-01-11 |
2009-07-16 |
Forerunner Pharma Research Co., Ltd. |
Anti-CLDN6 antibody
|
|
US7740844B2
(en)
|
2008-04-29 |
2010-06-22 |
Taiwan Liposome Co. Ltd |
Anti-VEGF monoclonal antibody
|
|
GB0921288D0
(en)
|
2009-12-04 |
2010-01-20 |
Health Prot Agency |
Therapies for preventing or suppressing clostridium difficile infection
|
|
AU2011239470B2
(en)
|
2010-04-15 |
2015-09-10 |
Progenics Pharmaceuticals, Inc. |
Antibodies for the treatment of Clostridium difficile-associated infection and disease
|
|
US9505847B2
(en)
*
|
2011-08-22 |
2016-11-29 |
Cnj Holdings Inc |
Clostridium difficile antibodies
|